Hepatic Impact of Etrasimod for Treatment of Moderately to Severely Active Ulcerative Colitis: An Integrated Safety Summary From the Etrasimod Ulcerative Colitis Clinical Program

被引：0

作者：

Regueiro, Miguel ^{[1
]}

Vermeire, Severine ^{[2
]}

Rubin, David T. ^{[3
]}

Dubinsky, Marla C. ^{[4
]}

Hart, Ailsa ^{[5
,6
]}

Wu, Joseph ^{[7
]}

Green, Jesse ^{[8
]}

Woolcott, John C. ^{[8
]}

Gorelick, Kenneth J. ^{[8
]}

McDonnell, Aoibhinn ^{[9
]}

Lazin, Krisztina ^{[10
]}

Peyrin-Biroulet, Laurent ^{[11
,12
]}

机构：

[1] CaseWestern Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH USA

[2] Univ Ziekenhuis Leuven, Leuven, Vlaams Brabant, Belgium

[3] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL USA

[4] Mt Sinai Kravis Childrens Hosp, New York, NY USA

[5] St Marks Hosp, London, England

[6] Imperial Coll, London, England

[7] Pfizer Inc, Cambridge, MA USA

[8] Pfizer Inc, Collegeville, PA USA

[9] Pfizer Ltd, Sandwich, England

[10] Pfizer AG, Zurich, Switzerland

[11] Lorraine Univ, Last Inserm U954, Vandoeuvre Les Nancy, Lorraine, France

[12] Lorraine Univ, CHU Nancy, Vandoeuvre Les Nancy, Lorraine, France

来源：

AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

S1072

引用

页码：S816 / S817

页数：2

共 50 条

[21] HISTOLOGIC REMISSION AND MUCOSAL HEALING IN A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDY OF ETRASIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Peyrin-Biroulet, Laurent
Panes, Julian
Chiorean, Michael V.
Zhang, Jinkun
Vermeire, Severine
Jairath, Vipul
Yarur, Andres J.
Cabell, Chris
Naik, Snehal
Sandborn, William J.
GASTROENTEROLOGY, 2019, 156 (06) : S217 - S217
[22] Histological remission and mucosal healing in a randomised, placebo-controlled, Phase 2 study of etrasimod in patients with moderately to severely active ulcerative colitis
Peyrin-Biroulet, L.
Panes, J.
Chiorean, M.
Zhang, J.
Vermeire, S.
Jairath, V.
Yarur, A.
Cabell, C.
Naik, S.
Sandborn, W. J.
JOURNAL OF CROHNS & COLITIS, 2019, 13 : S6 - S6
[23] Adalimumab for Induction of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
Reinisch, Walter
Sandborn, William J.
Hommes, Daniel W.
D'Haens, Geert R.
Hanauer, Stephen B.
Schreiber, Stefan
Panaccione, Remo
Fedorak, Richard N.
Tighe, Mary Beth
Huang, Bidan
Lazar, Andreas
GASTROENTEROLOGY, 2010, 138 (05) : S114 - S115
[24] Etrasimod: A Sphingosine-1-Phosphate Receptor Modulator for the Treatment of Ulcerative Colitis
Choi, David
Becker, Michelle
Ivanov, Marina
Bhat, Shubha
ANNALS OF PHARMACOTHERAPY, 2024, 58 (10) : 1054 - 1063
[25] Cost Per Clinical Outcomes With Biologics for the Treatment of Moderately to Severely Active Ulcerative Colitis
Jansen, Jeroen P.
Mody, Reema
Patel, Haridarshan
Lorenzi, Maria
Ursan, Iulia
Alberton, Mark
GASTROENTEROLOGY, 2015, 148 (04) : S1 - S2
[26] Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis
Kim, Jae Hyun
Cheon, Jae Hee
GUT AND LIVER, 2016, 10 (02) : 162 - 163
[27] Cost per clinical outcomes with biologics for the treatment of moderately to severely active ulcerative colitis
Jansen, J.
Mody, R.
Ursan, I.
Lorenzi, M.
Patel, H.
Alberton, M.
JOURNAL OF CROHNS & COLITIS, 2015, 9 : S239 - S240
[28] Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
Yasuo Suzuki
Satoshi Motoya
Hiroyuki Hanai
Takayuki Matsumoto
Toshifumi Hibi
Anne M. Robinson
Nael M. Mostafa
Jingdong Chao
Vipin Arora
Anne Camez
Roopal B. Thakkar
Mamoru Watanabe
Journal of Gastroenterology, 2014, 49 : 283 - 294
[29] Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis-A Safety Analysis
Afzali, Anita
Regueiro, Miguel
Yarur, Andres J.
Zabana, Yamile
Ng, Siew C.
Menon, Sujatha
Mcdonnell, Aoibhinn
Lazin, Krisztina
Keating, Michael
Bhattacharjee, Abhishek
Branquinho, Diogo
Bananis, Eustratios
Peyrin-Biroulet, Laurent
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2025,
[30] Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis
Suzuki, Yasuo
Motoya, Satoshi
Hanai, Hiroyuki
Matsumoto, Takayuki
Hibi, Toshifumi
Robinson, Anne M.
Mostafa, Nael M.
Chao, Jingdong
Arora, Vipin
Camez, Anne
Thakkar, Roopal B.
Watanabe, Mamoru
JOURNAL OF GASTROENTEROLOGY, 2014, 49 (02) : 283 - 294

← 1 2 3 4 5 →